0001127602-15-014763.txt : 20150417
0001127602-15-014763.hdr.sgml : 20150417
20150417172804
ACCESSION NUMBER: 0001127602-15-014763
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150415
FILED AS OF DATE: 20150417
DATE AS OF CHANGE: 20150417
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alkermes plc.
CENTRAL INDEX KEY: 0001520262
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981007018
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
BUSINESS PHONE: 00-353-1-772-8000
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC
DATE OF NAME CHANGE: 20110804
FORMER COMPANY:
FORMER CONFORMED NAME: Antler Science Two Ltd
DATE OF NAME CHANGE: 20110509
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FRATES JAMES M
CENTRAL INDEX KEY: 0001235598
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35299
FILM NUMBER: 15779088
MAIL ADDRESS:
STREET 1: 88 SIDNEY ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 021394136
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2015-04-15
0001520262
Alkermes plc.
ALKS
0001235598
FRATES JAMES M
CONNAUGHT HOUSE
1 BURLINGTON ROAD
DUBLIN 4 IRELAND
1
SVP & CFO, Alkermes plc
Ordinary Shares
2015-04-15
4
M
0
10000
9.21
A
88649
D
Ordinary Shares
2015-04-15
4
S
0
10000
62.4218
D
78649
D
Ordinary Shares
4000
I
By Sons
Ordinary Shares
57000
I
By GRAT
Employee Stock Option (Right to Buy)
9.21
2015-04-15
4
M
0
10000
0
D
2019-11-18
Ordinary Shares
10000
0
D
This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.035 to $62.75. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Shares held by James M. Frates Grantor Retained Annuity Trust dated March 14, 2014 (the "GRAT"). The Reporting Person is a trustee and beneficiary of the GRAT and may be deemed to hold voting and dispositive power with regard to the reported shares held by the GRAT.
These options are fully vested in accordance with their terms.
/s/ Jennifer Baptiste, attorney-in-fact for James M. Frates
2015-04-17